Inflammatory Osteoporosis in RA — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — TNF and IL-6 promote RANKL-dependent osteoclastogenesis and systemic bone resorption independently of current glucocorticoid use
Explanation lettering: D = shown as A · E = shown as B · A = shown as D · B = shown as E
C is correct. Active RA contributes directly to generalized bone loss: inflammatory mediators including TNF, IL-6 and IL-1 increase RANKL signalling, osteoclast differentiation and bone resorption. RA-associated fracture risk is multifactorial and can persist independently of current glucocorticoid use; immobility, sarcopenia and previous glucocorticoid exposure may add further risk. Standard weekly methotrexate is not the principal explanation for RA-associated osteoporosis, excluding A. Glucocorticoids compound risk but are not required, excluding B. Pannus causes local marginal erosions rather than direct extension into vertebral bodies, excluding D. Reduced mobility and falls contribute to fractures, but E is incorrect because inflammation also directly disrupts bone remodelling.
Reference: Fardellone P, Salawati E, Le Monnier L, Goëb V. Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review. Journal of Clinical Medicine. 2020;9:3361. https://pubmed.ncbi.nlm.nih.gov/33092162/